220 related articles for article (PubMed ID: 17768670)
1. Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2.
Lai CY; Hu HP; King CC; Wang WK
J Biomed Sci; 2008 Jan; 15(1):15-27. PubMed ID: 17768670
[TBL] [Abstract][Full Text] [Related]
2. A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles.
Hsieh SC; Liu IJ; King CC; Chang GJ; Wang WK
Virology; 2008 May; 374(2):338-50. PubMed ID: 18252258
[TBL] [Abstract][Full Text] [Related]
3. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.
Purdy DE; Chang GJ
Virology; 2005 Mar; 333(2):239-50. PubMed ID: 15721358
[TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02).
Mosimann AL; de Borba L; Bordignon J; Mason PW; dos Santos CN
J Virol Methods; 2010 Jan; 163(1):147-52. PubMed ID: 19761796
[TBL] [Abstract][Full Text] [Related]
5. Sub-genomic replicon and virus-like particles of Omsk hemorrhagic fever virus.
Yoshii K; Holbrook MR
Arch Virol; 2009; 154(4):573-80. PubMed ID: 19277843
[TBL] [Abstract][Full Text] [Related]
6. Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes.
Varnavski AN; Khromykh AA
Virology; 1999 Mar; 255(2):366-75. PubMed ID: 10069962
[TBL] [Abstract][Full Text] [Related]
7. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
Blaney JE; Sathe NS; Hanson CT; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2007 Feb; 4():23. PubMed ID: 17328799
[TBL] [Abstract][Full Text] [Related]
8. [Secreted expression of dengue virus type I envelope glycoprotein in 293T cells].
Miao F; Li C; Zhang S; Wang XF; Li JD; Zhang QF; Liu QZ; Wei Y; Hang XT; Liang MF; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):415-7. PubMed ID: 20718342
[TBL] [Abstract][Full Text] [Related]
9. Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells.
Brandler S; Brown N; Ermak TH; Mitchell F; Parsons M; Zhang Z; Lang J; Monath TP; Guirakhoo F
Am J Trop Med Hyg; 2005 Jan; 72(1):74-81. PubMed ID: 15728870
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
[TBL] [Abstract][Full Text] [Related]
11. Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis, and viral replication.
Alvarez DE; De Lella Ezcurra AL; Fucito S; Gamarnik AV
Virology; 2005 Sep; 339(2):200-12. PubMed ID: 16002117
[TBL] [Abstract][Full Text] [Related]
12. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
[TBL] [Abstract][Full Text] [Related]
13. The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion.
Huang CY; Butrapet S; Moss KJ; Childers T; Erb SM; Calvert AE; Silengo SJ; Kinney RM; Blair CD; Roehrig JT
Virology; 2010 Jan; 396(2):305-15. PubMed ID: 19913272
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic Fever patient.
Kinoshita H; Mathenge EG; Hung NT; Huong VT; Kumatori A; Yu F; Parquet MC; Inoue S; Matias RR; Natividad FF; Morita K; Hasebe F
Jpn J Infect Dis; 2009 Sep; 62(5):343-50. PubMed ID: 19762982
[TBL] [Abstract][Full Text] [Related]
15. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes.
Erb SM; Butrapet S; Moss KJ; Luy BE; Childers T; Calvert AE; Silengo SJ; Roehrig JT; Huang CY; Blair CD
Virology; 2010 Oct; 406(2):328-35. PubMed ID: 20708768
[TBL] [Abstract][Full Text] [Related]
16. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
[TBL] [Abstract][Full Text] [Related]
17. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the E gene sequences of three dengue virus type 1 isolates in Guangdong province].
Tian XD; Liu JW; Fang MY; Jiang LH; Ren RW; Hong WY; Cheng GF
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):54-7. PubMed ID: 15683998
[TBL] [Abstract][Full Text] [Related]
19. [Studies of the resistance of the recombinant alphavirus RNAs containing dengue-2 PrM gene to virus infection].
Yu M; Qin E; Zhao W; Hu Z; Yuan X
Wei Sheng Wu Xue Bao; 2001 Jun; 41(3):334-9. PubMed ID: 12549088
[TBL] [Abstract][Full Text] [Related]
20. Capsid-targeted viral inactivation can destroy dengue 2 virus from within in vitro.
Qin CF; Qin ED
Arch Virol; 2006 Feb; 151(2):379-85. PubMed ID: 16155726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
